May 1 |
Alpha Tau to Participate in May Investor Conferences
|
Mar 8 |
Alpha Tau Medical GAAP EPS of -$0.42
|
Mar 7 |
Alpha Tau Medical Announces Full Year 2023 Financial Results and Provides Corporate Update
|
Feb 26 |
Alpha Tau to Participate in Barclays 26th Annual Global Healthcare Conference
|
Feb 23 |
Alpha Tau Medical (NASDAQ:DRTS) Is In A Good Position To Deliver On Growth Plans
|
Jan 13 |
Alpha Tau Medical Ltd. (NASDAQ:DRTS) most popular amongst retail investors who own 58%, insiders hold 22%
|
Dec 20 |
Alpha Tau to Present at the 42nd Annual J.P. Morgan Healthcare Conference
|
Nov 29 |
Alpha Tau to Participate in Sidoti Small-Cap Conference
|
Nov 28 |
Alpha Tau Announces Highly Promising Interim Results from Safety and Feasibility Trial of Alpha DaRT Treatment of Advanced Pancreatic Cancer
|
Nov 20 |
Alpha Tau Submits to Japanese PMDA for Pre-Market Approval of Alpha DaRT in Patients with Recurrent Head and Neck Cancer
|